Orgenesis Price on September 19, 2024

ORGSDelisted Stock  USD 1.22  0.31  20.26%   
If you're considering investing in Orgenesis OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orgenesis stands at 1.22, as last reported on the 22nd of December, with the highest price reaching 1.55 and the lowest price hitting 1.10 during the day. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of -0.29, which implies the firm had a -0.29% return per unit of risk over the last 3 months. Orgenesis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orgenesis' Risk Adjusted Performance of (0.13), coefficient of variation of (587.98), and Variance of 127.61 to confirm the risk estimate we provide.
  
Orgenesis OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.289

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsORGS

Estimated Market Risk

 13.72
  actual daily
96
96% of assets are less volatile

Expected Return

 -3.96
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.29
  actual daily
0
Most of other assets perform better
Based on monthly moving average Orgenesis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orgenesis by adding Orgenesis to a well-diversified portfolio.

Related Headline

Acrivon Therapeutics, Headline on 19th of September 2024

HC Wainwright reiterated their buy rating on shares of Acrivon Therapeutics in a research note released on Monday, Benzinga reports. They currently have a 22.00 price objective on the stock. ACRV has been the subject of a number of other reports. Piper Sandler Companies reiterated a buy rating and issued a

Orgenesis Valuation on September 19, 2024

It is possible to determine the worth of Orgenesis on a given historical date. On September 19, 2024 Orgenesis was worth 5.5 at the beginning of the trading date compared to the closed value of 5.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orgenesis otc stock. Still, in general, we apply an absolute valuation method to find Orgenesis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orgenesis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orgenesis' related companies.
 Open High Low Close Volume
  5.65    5.78    5.42    5.42    13,917  
09/19/2024
  5.50    5.75    5.33    5.50    8,744  
  5.65    5.70    5.10    5.17    22,960  
Backtest Orgenesis  |  Orgenesis History  |  Orgenesis Valuation   PreviousNext  
Open Value
5.5
5.5
Closing Value
46.65
Upside

Orgenesis Trading Date Momentum on September 19, 2024

On September 20 2024 Orgenesis was traded for  5.17  at the closing time. The top price for the day was 5.70  and the lowest listed price was  5.10 . The trading volume for the day was 23 K. The trading history from September 20, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 6.00% . The trading delta at closing time against the current closing price is 5.45% .

Orgenesis Fundamentals Correlations and Trends

By evaluating Orgenesis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orgenesis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orgenesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Orgenesis OTC Stock history

Orgenesis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orgenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orgenesis will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orgenesis stock prices may prove useful in developing a viable investing in Orgenesis
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.

Orgenesis OTC Stock Technical Analysis

Orgenesis technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Orgenesis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Orgenesis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Orgenesis Period Price Range

Low
December 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Orgenesis cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Orgenesis December 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Orgenesis otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orgenesis shares will generate the highest return on investment. By undertsting and applying Orgenesis otc stock market strength indicators, traders can identify Orgenesis entry and exit signals to maximize returns

Orgenesis Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Orgenesis' price direction in advance. Along with the technical and fundamental analysis of Orgenesis OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orgenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Orgenesis OTC Stock

If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments